BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19564161)

  • 1. Serum 99th centile values for two heart-type fatty acid binding protein assays.
    Bathia DP; Carless DR; Viswanathan K; Hall AS; Barth JH
    Ann Clin Biochem; 2009 Nov; 46(Pt 6):464-7. PubMed ID: 19564161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
    J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and analytical evaluation of an immunoturbidimetric heart-type fatty acid-binding protein assay.
    Carless DR; Wnęk M; Knox C; Harrison KR; Calder N; Hall AS; Barth JH
    Scand J Clin Lab Invest; 2013 Feb; 73(1):48-53. PubMed ID: 23113681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.
    Kilcullen N; Viswanathan K; Das R; Morrell C; Farrin A; Barth JH; Hall AS;
    J Am Coll Cardiol; 2007 Nov; 50(21):2061-7. PubMed ID: 18021874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of fatty acid-binding proteins in idiopathic membranous nephropathy.
    Hofstra JM; Deegens JK; Steenbergen EJ; Wetzels JF
    Nephrol Dial Transplant; 2008 Oct; 23(10):3160-5. PubMed ID: 18403431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart-type fatty acid binding protein--a reliable marker of myocardial necrosis in a heterogeneous group of patients with acute coronary syndrome without persistent ST elevation.
    Figiel Ł; Kasprzak JD; Peruga J; Lipiec P; Drozdz J; Krzemińska-Pakuła M; Smigielski J
    Kardiol Pol; 2008 Mar; 66(3):253-9, discussion 260-1. PubMed ID: 18393112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies.
    Mollenhauer B; Steinacker P; Bahn E; Bibl M; Brechlin P; Schlossmacher MG; Locascio JJ; Wiltfang J; Kretzschmar HA; Poser S; Trenkwalder C; Otto M
    Neurodegener Dis; 2007; 4(5):366-75. PubMed ID: 17622779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The determination of the 99th centile level for troponin assays in an Australian reference population.
    Tate JR; Ferguson W; Bais R; Kostner K; Marwick T; Carter A
    Ann Clin Biochem; 2008 May; 45(Pt 3):275-88. PubMed ID: 18482916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
    O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
    Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy.
    Nakamura T; Sugaya T; Node K; Ueda Y; Koide H
    Am J Kidney Dis; 2006 Mar; 47(3):439-44. PubMed ID: 16490622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty acid-binding protein as marker for renal injury.
    Pelsers MM
    Scand J Clin Lab Invest Suppl; 2008; 241():73-7. PubMed ID: 18569970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heart-type fatty acid-binding protein detection for early diagnosis of acute coronary syndrome].
    Zhang P; Wang Q; Zheng L; Zeng FY; Qiu YR
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):358-60. PubMed ID: 16546748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in serum concentration of human heart-type fatty acid-binding protein following elective coronary intervention.
    Sbarouni E; Georgiadou P; Sklavainas I; Chaidaroglou A; Panagiotakos D; Degiannis D; Voudris V
    Biomarkers; 2009 Aug; 14(5):317-20. PubMed ID: 19552571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early markers of myocardial injury: cTnI is enough.
    Ilva T; Lund J; Porela P; Mustonen H; Voipio-Pulkki LM; Eriksson S; Pettersson K; Tanner P; Pulkki K
    Clin Chim Acta; 2009 Feb; 400(1-2):82-5. PubMed ID: 18992232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart fatty acid binding protein as a marker for postmortem detection of early myocardial damage.
    Meng X; Ming M; Wang E
    Forensic Sci Int; 2006 Jun; 160(1):11-6. PubMed ID: 16182485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis.
    Yeung DC; Xu A; Cheung CW; Wat NM; Yau MH; Fong CH; Chau MT; Lam KS
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1796-802. PubMed ID: 17510463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of the measurements of urinary liver-type fatty acid binding protein levels in patients with acute coronary syndrome.
    Matsumori R; Shimada K; Kiyanagi T; Hiki M; Fukao K; Hirose K; Ohsaka H; Miyazaki T; Kume A; Yamada A; Takagi A; Ohmura H; Miyauchi K; Daida H
    J Cardiol; 2012 Sep; 60(3):168-73. PubMed ID: 22658694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of heart-type fatty acid binding protein in early diagnosis of acute coronary syndrome.
    Valle HA; Riesgo LG; Bel MS; Gonzalo FE; Sanchez MS; Oliva LI
    Eur J Emerg Med; 2008 Jun; 15(3):140-4. PubMed ID: 18460953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of heart-type fatty acid-binding protein for left ventricular remodelling and clinical outcome of hypertensive patients with mild-to-moderate aortic valve diseases.
    Iida M; Yamazaki M; Honjo H; Kodama I; Kamiya K
    J Hum Hypertens; 2007 Jul; 21(7):551-7. PubMed ID: 17392813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.